Novo Nordisk (0QIU) Gets a Buy from Goldman Sachs
In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...
pharmaphorum23h
High-dose semaglutide ramps up weight loss, says Novo
A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...
The £40 weight loss jabs illegally sold on TikTok that could put you in hospital
Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...
Jim Cramer’s Comments on Novo Nordisk A/S (NVO) Surrounded Its Weight Loss Drugs Being Picked For Medicare Price Negotiations
We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...
Future Market Insights6h
Global Disposable Pen Injectors Market to Reach USD 54.4 Billion by 2033 at a CAGR of 7.9%
In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...